FRASER CRAIG (President and CEO) received a stock award from WINDTREE THERAPEUTICS INC /DE/
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/7/2022ACC: 0001437749-22-005417
DirectorOfficer· President and CEO
Since Nov 2018
+417.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
417.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+166.90K
Price / share
—
Trade value
—
% of position
437.4%
3/4/2022
38.16K→205.06K
Total
Net shares
+166.90K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2022 | A · Award | +166.90K | — | — | 437.4% | 38.16K | 205.06K |
| Total | +166.90K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250.40K shares
Shares
+250.40K
Strike price
1.02
Held after
250.40K
Exercisable
—
3/4/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock250.40K shares | 3/4/2022 | A · Award | +250.40K | 1.02 | — | 250.40K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned147.00
Total
147.00 indirect147.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 147.00 | Indirect |
| Total | 147.00 | 147.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported